Evaluation of the effectiveness of a multi-component intervention at the workplace for the prevention and management of musculoskeletal pain in nursing staff: design of a study where hospital units are randomly selected to receive the intervention or usual care of occupational health. The INTEVAL_Spain project.

ISRCTN ISRCTN15780649
DOI https://doi.org/10.1186/ISRCTN15780649
Secondary identifying numbers FIS FEDER/ PI14/01959
Submission date
25/05/2018
Registration date
13/07/2018
Last edited
06/08/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Musculoskeletal pain (MSP) is the most common work-related health problem in Europe and Spain; in order to reduce sickness absence this is one of the greatest health challenges. Previous interventions have been developed to improve the return-to-work of employees with MSP, but combined approaches and exhaustive evaluation are required. The objective of INTEVAL_Spain project is to evaluate the effectiveness of a multi-component intervention at the workplace to prevent and manage MSP in workers.

Who can participate?
Adult nursing staff who work in the study units

What does the study involve?
Hospital units are randomly allocated to one of two arms. Those in the first arm receive an intervention for 1 year, which is made up of three components:
a) Identifying and improving the working conditions associated with the onset of MSP
b) Diagnosis, management and support for workers with MSP
c) Regular activities associated with health benefits

Those in the control group only receive usual care.
Participants take a series of questionnaires before the intervention, and at 6 and 12 months.

What are the possible benefits and risks of participating?
There are no direct benefits or risks for those taking part in the study.
Where is the study run from?
1. Parc de Salut Mar (Spain)
2. Corporació Santaria Parc Tauli (Spain)

When is the study starting and how long is it expected to run for?
November 2015 to June 2019

Who is funding the study?
Carlos III Health Institute (Instituto de Salud Carlos II) (Spain)

Who is the main contact?
Mrs Mercè Soler Font (scientific)
merce.soler01@estudiant.upf.edu

Contact information

Mrs Mercè Soler Font
Scientific

Dr, Aiguader, 88
Barcelona
08003
Spain

Phone +34933160876
Email merce.soler01@estudiant.upf.edu
Mrs Mercè Soler Font
Public

Dr. Aiguader, 88
Barcelona
08003
Spain

Phone +34933160876
Email cisal@upf.edu

Study information

Study designTwo-armed cluster randomized controlled trial
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleEvaluation of the effectiveness of a multi-component intervention at the workplace for the prevention and management of musculoskeletal pain in nursing staff: design of a cluster-randomized controlled trial. The INTEVAL_Spain project.
Study acronymINTEVAL_Spain
Study objectivesAn innovative multicomponent intervention at the workplace that combines primary, secondary and tertiary prevention, and health promotion, will have a positive impact on musculoskeletal health in healthcare workers by reducing the frequency and duration of MSP and will be cost-effective for the company/hospital. Considering the prevalence of MSP in workers as a representative indicator of the impact on health, we estimate that this multicomponent intervention will reduce this outcome by 25%.
Ethics approval(s)Clinical Research Ethical Committee of the Parc de Salut Mar (CEIC-Parc de Salut Mar), 14/07/2014, ref: 2014/5714/1
Health condition(s) or problem(s) studiedWork related-musculoskeletal pain and sickness absence
InterventionThe study is designed as a two-armed cluster randomized controlled trial, with a late intervention control group where clusters are independent hospital units, and participants are the nursing staff- workers exposed to musculoskeletal risks. This study is a randomized trial, in which the employees are randomized after signing informed consent together with formal information about the study. A total of eight clusters have been selected for the randomization. The condition of being included in the intervention or the control group cannot be blinded. All clusters are Hospital Units where nurses and aids are at risk of high physical demands due to the characteristics of the patients cared for in them (dependents and semi-collaborative patients). All data collected from both groups (intervention and control groups) is anonymized before the analyses. An independent researcher assigns the clusters to the intervention or to the control group by a simple randomization stratified by center, obtaining 4 clusters in each group.

The intervention is based on the available scientific evidence and consists of three components that encompass the three levels of prevention and health promotion:
a) participatory ergonomics, to identify and improve the working conditions associated with the onset of MSP in workers
b) case management, including early diagnosis and personalized management of workers with disabling MSP (secondary prevention) and the adaptation and facilitation of return to work after a sickness absence episode and/or workers’ maintenance in their jobs (tertiary prevention)
c) health promotion, through activities scheduled during the second and third quarter until the end of the intervention, associated with evidence based health benefits (physical exercise, stress management, healthy eating and education on health beliefs).
The intervention group also receive care as usual, and the control group will receive only usual care of occupational health.

The intervention lasts one year, and data are collected at baseline, 6 and 12 months follow-up.
Intervention typeMixed
Primary outcome measure1. Musculoskeletal self-perceived pain data are collected using the Spanish version of the Nordic Questionnaire, at baseline, 6 months and 12 months follow-up.
2. Sickness absence data are collected from one year before the intervention was implemented until the end of the intervention, and number of episodes and their duration is analyzed.
Secondary outcome measures1. Work functioning is measured by the Work Role Functioning Questionnaire-Spanish Version at baseline, 6 and 12 months follow up.
2. Quality of life is measured by the European Questionnaire 5 Dimensions 3 Levels ( EQ-5D-3L) at baseline, 6 and 12 months follow up.
3. Preventive culture is measured by the Institute for Work & Health Organizational Performance Metric (IWH-OPM), at baseline, 6 and 12 months follow up.
Overall study start date01/11/2015
Completion date30/06/2019

Eligibility

Participant type(s)Health professional
Age groupAdult
SexBoth
Target number of participantsFrom the sample calculations, 8 clusters of 20 to 60 participants each have agreed to participate.
Total final enrolment473
Key inclusion criteria1. Nursing staff (nurses and aides) including employees in sickness absence who work in the study units/clusters
2. Voluntarily willing to participate in the study
Key exclusion criteria1. Temporary staff who work at the study units only infrequently and/or for short periods
2. Employees on leave, except on sickness absence, during most of the study period
Date of first enrolment01/05/2016
Date of final enrolment01/09/2016

Locations

Countries of recruitment

  • Spain

Study participating centres

Parc de Salut Mar
Barcelona
08003
Spain
Corporació Santaria Parc Taulí
Sabadell
08208
Spain

Sponsor information

FUNDACIÓ IMIM
Research organisation

Dr. Aiguader
88 - PRBB Building
Barcelona
08003
Spain

Phone +34 933 160 876
Email salutlaboral@upf.edu
ROR logo "ROR" https://ror.org/042nkmz09

Funders

Funder type

Government

Instituto de Salud Carlos III
Government organisation / National government
Alternative name(s)
SaludISCIII, InstitutodeSaludCarlosIII, Instituto de Salud Carlos III | Madrid, Spain, Carlos III Institute of Health, Institute of Health Carlos III, Carlos III Health Institute, ISCIII
Location
Spain
Prevent Foundation - Barcelona (Spain)

No information available

Results and Publications

Intention to publish date01/03/2019
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publications in a high-impact peer reviewed journal during the period comprised from 01/09/2018 to 01/03/2019.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available. The study participants signed a form to give their informed consent to participate in the study. The objectives and scope of the study were specified in the form, informing that all the personal data as well as the information provided at all times would be anonymous and would only be used in the INTEVAL study.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 28/03/2019 23/11/2020 Yes No
Results article 18/11/2019 19/07/2021 Yes No
Other publications Process evaluation 06/10/2021 23/08/2023 Yes No
Other publications Cost effectiveness 05/08/2024 06/08/2024 Yes No

Editorial Notes

06/08/2024: Publication reference added.
23/08/2023: Publication reference added.
19/07/2021: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
23/11/2020: Publication reference added.
04/12/2018: Changed all references to ''musculoskeletal disorders'' to ''musculoskeletal pain''